Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$7.33 - $9.4 $586,400 - $752,000
80,000 Added 44.95%
257,974 $2.41 Million
Q1 2022

May 16, 2022

SELL
$7.97 - $9.85 $956,400 - $1.18 Million
-120,000 Reduced 40.27%
177,974 $1.51 Million
Q4 2021

Feb 14, 2022

BUY
$8.85 - $10.42 $1.58 Million - $1.85 Million
177,974 Added 148.31%
297,974 $2.86 Million
Q3 2021

Nov 12, 2021

BUY
$9.25 - $10.76 $1.11 Million - $1.29 Million
120,000 New
120,000 $1.22 Million

Others Institutions Holding PROC

About Procaps Group, S.A.


  • Ticker PROC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 112,824,000
  • Market Cap $196M
  • Description
  • Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...
More about PROC
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.